Saturn V Capital Management LP
AUSTIN TX · SEC CIK 0001964437
$6.97亿2026Q2 申报市值
23持仓数
75.6%前十大占比 · 第一大 11.9%
3 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q2 买入最多 按季末市值估算
TRVI 新建仓+$1,962.06万
SGMT 新建仓+$1,143.98万
IMMX 加仓+$994.75万
CELC 加仓+$924.99万
ZURA 加仓+$803.08万
2026Q2 卖出最多 按季末市值估算
COGT 清仓-$2,411.92万
OVID 减仓-$942.47万
ALMS 减仓-$806.58万
ABVX 减仓-$317.57万
MNPR 减仓-$311.57万
2026Q2 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| AMLX | AMYLYX PHARMACEUTICALS INC | $8,304.89万 | 11.91% | 4,624,101 | 274,216 | 6.3% | $492.49万 | 加仓 |
| ALMS | ALUMIS INC | $8,204.06万 | 11.76% | 2,915,443 | -286,632 | -9.0% | -$806.58万 | 减仓 |
| ABVX | ABIVAX SA | $6,914.40万 | 9.91% | 518,865 | -23,831 | -4.4% | -$317.57万 | 减仓 |
| PCVX | VAXCYTE INC | $4,957.99万 | 7.11% | 852,914 | 28,382 | 3.4% | $164.98万 | 加仓 |
| IMMX | IMMIX BIOPHARMA INC | $4,802.84万 | 6.89% | 4,658,429 | 964,844 | 26.1% | $994.75万 | 加仓 |
| PHVS | PHARVARIS N V | $4,544.23万 | 6.52% | 1,314,122 | 112,720 | 9.4% | $389.79万 | 加仓 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $3,878.12万 | 5.56% | 160,938 | -2,023 | -1.2% | -$48.75万 | 减仓 |
| CELC | CELCUITY INC | $3,874.27万 | 5.55% | 370,318 | 88,414 | 31.4% | $924.99万 | 加仓 |
| IRON | DISC MEDICINE INC | $3,837.88万 | 5.50% | 524,730 | 74,804 | 16.6% | $547.12万 | 加仓 |
| CADL | CANDEL THERAPEUTICS INC | $3,402.80万 | 4.88% | 3,303,686 | 407,098 | 14.1% | $419.31万 | 加仓 |
| XFOR | X4 PHARMACEUTICALS INC | $3,256.55万 | 4.67% | 6,973,343 | 516,697 | 8.0% | $241.30万 | 加仓 |
| MNPR | MONOPAR THERAPEUTICS INC | $2,888.59万 | 4.14% | 311,976 | -33,650 | -9.7% | -$311.57万 | 减仓 |
| DYN | DYNE THERAPEUTICS INC | $2,348.69万 | 3.37% | 1,057,493 | 90,884 | 9.4% | $201.85万 | 加仓 |
| TRVI | TREVI THERAPEUTICS INC | $1,962.06万 | 2.81% | 1,052,043 | 1,052,043 | — | $1,962.06万 | 新建仓 |
| ZURA | ZURA BIO LTD | $1,239.66万 | 1.78% | 2,101,119 | 1,361,159 | 184.0% | $803.08万 | 加仓 |
| SGMT | SAGIMET BIOSCIENCES INC | $1,143.98万 | 1.64% | 1,479,918 | 1,479,918 | — | $1,143.98万 | 新建仓 |
| OCS | OCULIS HOLDING AG | $949.93万 | 1.36% | 684,880 | 168,119 | 32.5% | $233.18万 | 加仓 |
| IKT | INHIBIKASE THERAPEUTICS INC | $785.42万 | 1.13% | 3,869,056 | 5,611 | 0.1% | $1.14万 | 加仓 |
| VIR | VIR BIOTECHNOLOGY INC | $785.29万 | 1.13% | 770,643 | 770,643 | — | $785.29万 | 新建仓 |
| IVVD | INVIVYD INC | $732.14万 | 1.05% | 8,392,288 | -2,556,796 | -23.4% | -$223.05万 | 减仓 |
| ANRO | ALTO NEUROSCIENCE INC | $482.49万 | 0.69% | 182,829 | 93,830 | 105.4% | $247.62万 | 加仓 |
| — | SATELLOS BIOSCIENCE INC | $272.12万 | 0.39% | 350,000 | 0 | 0.0% | — | 不变 |
| OVID | OVID THERAPEUTICS INC | $178.36万 | 0.26% | 663,060 | -3,503,606 | -84.1% | -$942.47万 | 减仓 |
| COGT | COGENT BIOSCIENCES INC | $0 | 0.00% | 0 | -626,635 | -100.0% | -$2,411.92万 | 清仓 |